Study number 8548-638
Dates
Nov 17 2025-Jan 13 2026
Location
Madison, Wisconsin
Age
18-55
Gender
Male and Female
Smoker
No
Compensation
$8,378
Group
C 2b
The investigational drug in this research is being developed for the potential treatment of plycythemia vera, which, is a certain kind of cancer where the body produces too many red blood cells.
Women Eligibility Criteria
Body Mass Index (BMI)
Smoking Criteria
Medication Restrictions
Screening Procedures
Refer a friend & receive $350 per qualified referral
C2b:
Check-in: Nov 17
Check-out: Nov 20
Check-in: Nov 24
Check-out: Nov 25
Check-in: Dec 15
Check-out: Dec 16
Check-in: Jan 12
Check-out: Jan 13
Follow-up Visits: Dec 2, Dec 30